AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Enliven Therapeutics, Inc.

$41.65 +$26.11 (+168.02%)
NASDAQ · 09 Oct 2026 13:58 UTC
Previous Close
$40.63
Day Range
$40.29$41.65
Year Range
$14.79$62.32
Market Cap
2.98B
AVG Volume
1.43M
Trailing/Forward PE
-25.56/-
PEG ratio
-4.29
Dividend Yield
-
Next Earnings Date
2026-11-11
Primary Exchange
NASDAQUS
Net Income (USD) · TTM
-150M-100M-50M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ELVN Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-105.93M
26 Q1-98.78M
25 Q4-103.69M
25 Q3-97.21M
25 Q2-100.22M
25 Q1-94.83M
24 Q4-89.02M
24 Q3-85.21M
24 Q2-82.83M
24 Q1-79.6M
Operating Income (USD) · TTM
-150M-100M-50M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ELVN Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-124.41M
26 Q1-115.79M
25 Q4-119.66M
25 Q3-112.27M
25 Q2-114.24M
25 Q1-110.26M
24 Q4-104.55M
24 Q3-100.39M
24 Q2-97.57M
24 Q1-93.1M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book
Enliven Therapeutics, Inc.
ELVN
Stockpicker

Video analysis: ELVN

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ELVN

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.